Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

LTRN

Insider Sentiment (TTM):

Last Purchase:2026-05-12Last Sale:2025-06-13Shares Purchased (TTM):97,088Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:2,069,151Shares Outstanding:11,253,030Institutional Ownership Pct.:18.39%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Cash And Cash Equivalents At Carrying Value	7	5	4	8	6	6	8	8	13	18	22	26
Assets Current
Assets Current	8	7	11	13	17	21	25	30	35	39	43	47
Marketable Securities Current	1	1	6	4	10	13	17	20	20	20	19	19
Prepaid Expense And Other Assets Current	1	1	1	1	1	1	1	2	2	1	2	3
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Costs	0	0	0	-	-	-	-	-	-	-	-	-
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	9	7	11	14	17	21	26	30	36	40	44	48
Liabilities Current
Liabilities Current	4	4	5	4	5	4	4	4	5	4	3	2
Accounts Payable And Accrued Liabilities Current	4	4	4	4	5	4	4	3	4	4	3	2
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Liability Noncurrent	-	-	-	-	0	0	0	0	0	0	0	0
Liabilities	12	4	5	4	5	4	4	4	5	4	3	2
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Additional Paid In Capital	100	100	100	99	97	97	97	97	97	96	96	97
Stockholders Equity	-3	3	7	10	13	17	21	27	31	36	41	45
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	0	0	0	0	-0	-0	0	-0	-0
Retained Earnings Accumulated Deficit	-104	-96	-93	-89	-85	-81	-76	-70	-66	-61	-55	-51
Liabilities And Stockholders Equity	9	7	11	14	17	21	26	30	36	40	44	48
Preferred Stock Shares Authorized	1	1	1	1	1	1	1	1	1	1	1	1
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	25	25	25	25	25	25	25	25	25	25	25	25
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Issued	13	11	11	11	11	11	11	11	11	11	11	11
Shares Outstanding	13	11	11	11	11	11	11	11	11	11	11	11

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	14.33%	26.43%	-15.61%	-	-	-	-	-	-	-	-	-
2025	-13.99%	-15.80%	23.58%	-9.45%	-13.66%	-15.76%	7.76%	-10.63%	-9.48%	99.19%	183.40%	206.88%
2024	-10.87%	-31.42%	-32.75%	-3.31%	-10.76%	-21.04%	-6.14%	0.00%	57.89%	-8.06%	-10.75%	-18.01%
2023	-	-	-	-	-	-	33.57%	52.86%	53.21%	-35.84%	-38.15%	-43.98%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.96	1.87	2.40	3.33	3.52	4.86	5.83	8.31	7.67	9.98	16.18	21.05
Quick Ratio	1.70	1.67	2.25	3.06	3.26	4.60	5.54	7.79	7.23	9.70	15.42	19.94
Working Capital	4.14M	3.28M	6.30M	9.42M	12.32M	16.54M	20.92M	26.32M	30.69M	35.52M	40.66M	45.17M
Leverage & Debt
Debt to Equity	-3.67	1.10	0.69	0.42	0.39	0.26	0.21	0.14	0.15	0.11	0.07	0.05
Debt Ratio	1.37	0.52	0.41	0.30	0.28	0.20	0.17	0.12	0.13	0.10	0.06	0.05
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-1.50	-1.41	-1.57	-1.75	-1.78	-1.84	-1.93	-1.77	-1.65	-1.63	-1.47	-1.40
Free Cash Flow Per Share TTM	-1.18	-1.34	-1.44	-1.15	-1.25	-1.77	-1.66	-1.60	-1.42	-1.27	-1.32	-1.26
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-3.10%	-19.95%	-17.62%	-0.90%	8.46%	13.36%	30.20%	25.96%	24.46%	25.19%	11.93%	5.12%
EPS Growth (1Y)	-15.88%	-23.28%	-18.65%	-1.54%	8.20%	12.92%	31.16%	27.06%	25.59%	26.53%	12.02%	4.94%
Valuation Metrics
P/E TTM	-2.78	-0.97	-1.93	-2.49	-1.77	-1.92	-1.65	-2.07	-2.83	-5.39	-2.91	-2.44
P/B TTM	-16.10	4.47	5.05	4.92	2.72	2.28	1.62	1.49	1.62	2.64	1.13	0.82
Market Cap	51.80M	15.42M	33.02M	47.13M	34.08M	38.18M	34.33M	39.50M	50.24M	94.54M	46.41M	37.02M
Enterprise Value	45.14M	10.50M	28.60M	38.74M	28.02M	31.80M	26.82M	31.40M	37.27M	76.18M	24.47M	11.45M
Calculated Values
Free Cash Flow TTM	-14.68M	-15.08M	-15.68M	-12.49M	-13.50M	-19.13M	-17.83M	-17.24M	-15.27M	-13.67M	-14.37M	-13.65M
Net Debt	-6.66M	-4.92M	-4.42M	-8.39M	-6.06M	-6.38M	-7.51M	-8.10M	-12.98M	-18.36M	-21.94M	-25.57M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-12Purchase

Owner: Keyser, D Jeffrey

Title: -

Shares: 48,544

Price/Share: $2.06

Value: $100,000.64

Shares Owned: 94,303

Relationship: Director

Ownership: Direct

2026-05-12Purchase

Owner: Schalop, Lee Troy

Title: -

Shares: 48,544

Price/Share: $2.06

Value: $100,000.64

Shares Owned: 48,544

Relationship: Director

Ownership: Direct

2025-06-13Sale

Owner: Bios, Fund Ii Qp, Lp, Bio…

Title: -

Shares: 40,000

Price/Share: $3.09

Value: $123,600.00

Shares Owned: 49,957

Relationship: TenPercentOwner

Ownership: Indirect

2025-06-13Sale

Owner: Bp, Directors, Lp, Cavu A…

Title: -

Shares: 40,000

Price/Share: $3.09

Value: $123,600.00

Shares Owned: 49,957

Relationship: TenPercentOwner

Ownership: Indirect

2025-06-12Sale

Owner: Cavu, Advisors, Llc, Bp D…

Title: -

Shares: 60,647

Price/Share: $3.38

Value: $204,986.86

Shares Owned: 51,860

Relationship: TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-12	Keyser, D Jeffrey	Director	-	Direct	Purchase	48,544	2.06	$100,000.64	94,303	4
2026-05-12	Schalop, Lee Troy	Director	-	Direct	Purchase	48,544	2.06	$100,000.64	48,544	4
2025-06-13	Bios, Fund Ii Qp, Lp, Bio…	TenPercentOwner	-	Indirect	Sale	40,000	3.09	$123,600.00	49,957	4
2025-06-13	Bp, Directors, Lp, Cavu A…	TenPercentOwner	-	Indirect	Sale	40,000	3.09	$123,600.00	49,957	4
2025-06-12	Cavu, Advisors, Llc, Bp D…	TenPercentOwner	-	Indirect	Sale	60,647	3.38	$204,986.86	51,860	4
2025-06-12	Bios, Fund I, Lp, Bios Fu…	TenPercentOwner	-	Indirect	Sale	60,647	3.38	$204,986.86	51,860	4
2025-05-29	Cavu, Advisors, Llc, Bp D…	TenPercentOwner	-	Indirect	Sale	20,200	3.03	$61,206.00	54,792	4
2025-05-29	Bios, Advisors Gp, Llc, B…	TenPercentOwner	-	Indirect	Sale	20,200	3.03	$61,206.00	54,792	4
2024-05-24	Fletcher, Aaron G.L., Bio…	TenPercentOwner	-	Indirect	Sale	20,000	6.33	$126,600.00	57,467	4
2024-05-24	Cavu, Advisors, Llc, Krei…	TenPercentOwner	-	Indirect	Sale	20,000	6.33	$126,600.00	57,467	4
2024-02-29	Bp, Directors, Lp, Cavu M…	TenPercentOwner	-	Indirect	Sale	19,703	4.87	$95,953.61	60,256	4
2024-02-29	Bios, Equity Partners Ii,…	TenPercentOwner	-	Indirect	Sale	19,703	4.87	$95,953.61	60,256	4
2024-01-17	Bp, Directors, Lp, Cavu M…	TenPercentOwner	-	Indirect	Sale	58,889	4.20	$247,333.80	73,646	4
2024-01-17	Bios, Fund I, Lp, Bios Fu…	TenPercentOwner	-	Indirect	Sale	58,889	4.20	$247,333.80	73,646	4
2023-11-29	Cavu, Management, Lp, Cav…	TenPercentOwner	-	Indirect	Sale	145,348	3.44	$499,997.12	217,553	4
2023-11-29	Fletcher, Aaron G.L., Bio…	TenPercentOwner	-	Indirect	Sale	145,348	3.44	$499,997.12	217,553	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

18.39%

Inst. Shares: 2,069,151

Shares Outstanding: 11,253,030

2025-12-31

20.92%

Inst. Shares: 2,279,809

Shares Outstanding: 10,898,175

2025-09-30

20.79%

Inst. Shares: 2,252,681

Shares Outstanding: 10,833,393

2025-06-30

20.61%

Inst. Shares: 2,222,812

Shares Outstanding: 10,784,725

2025-03-31

22.36%

Inst. Shares: 2,411,031

Shares Outstanding: 10,784,725

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	2,069,151	11,253,030	18.39%
2025-12-31	2,279,809	10,898,175	20.92%
2025-09-30	2,252,681	10,833,393	20.79%
2025-06-30	2,222,812	10,784,725	20.61%
2025-03-31	2,411,031	10,784,725	22.36%
2024-12-31	2,499,825	10,762,319	23.23%
2024-09-30	1,332,770	10,763,351	12.38%
2024-06-30	1,282,818	10,758,805	11.92%
2024-03-31	1,028,370	10,742,797	9.57%
2023-12-31	1,052,773	10,842,365	9.71%
2023-09-30	1,100,330	10,857,366	10.13%
2023-06-30	1,015,460	10,857,040	9.35%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Lantern Pharma Inc. (LTRN) — SEC Financial Statements & Analysis

Lantern Pharma Inc. (LTRN) is a pharmaceutical preparations company, incorporated in TX. Lantern Pharma Inc. trades on Nasdaq as: LTRN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Lantern Pharma Inc. reported a Debt-to-Equity ratio of -3.67x, a Price-to-Book (P/B) ratio of -16.10x (TTM), at a market cap of $51.80M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: -3.67x
P/B TTM: -16.10x
Market Cap: $51.80M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Lantern Pharma Inc. in?

Lantern Pharma Inc. (LTRN) operates in the Pharmaceutical Preparations industry.

What is LTRN's market cap?

Lantern Pharma Inc. (LTRN) has a market capitalization of $51.80M as of 2026-06-30.

What exchange does LTRN trade on?

Lantern Pharma Inc. (LTRN) trades on the Nasdaq.

Where is Lantern Pharma Inc. incorporated?

Lantern Pharma Inc. is incorporated in TX.